Hepatitis E and Thrombotic Thrombocytopenic Purpura: A Rare Case Study
Hepatitis E virus (HEV) is a significant global public health concern, often transmitted through contaminated food and water. Beyond its well-known role in causing liver inflammation, new evidence highlights that HEV can lead to various extraliver manifestations, including kidney disorders and neurological conditions.
One relatively uncommon complication is thrombocytopenia, a condition marked by a low platelet count, occurring in approximately 11% of HEV patients. While most cases are mild and resolve on their own, rare instances of thrombotic thrombocytopenic purpura (TTP) have been documented in association with HEV infection.
Understanding Thrombotic Thrombocytopenic Purpura (TTP)
TTP is a life-threatening blood disorder characterized by fever, hemolytic anemia, thrombocytopenia, kidney dysfunction, and neurological symptoms. The condition stems from a deficiency in ADAMTS13, an enzyme crucial for preventing excessive clot formation in small blood vessels. A majority of TTP cases are idiopathic, often triggered by infections, cancers, drugs, or pregnancy.
While HEV-linked TTP has been reported in case studies, this case presents the second documented instance of an inaugural TTP episode occurring concurrently with acute HEV viremia, further supporting the virus’s potential role in causing TTP.
Case Presentation
In July 2023, a 74-year-old female, described as a farmer, sought medical attention for intermittent fever, fatigue, nausea, and.persistent jaundice lasting for 10 days. Despite no history of alcohol consumption, herbal medicine use, or tobacco smoking, she had a history of hypertension and type 2 diabetes, along with two previous surgeries to treat throat and colon polyps.
A few days before the symptoms began, she had eaten pickled food for 10 consecutive days. Upon admission, the patient exhibited an elevated body temperature of 38.9°C, a pulse rate of 103 beats per minute, blood pressure of 127/77 mmHg, respiratory rate of 18 breaths per minute, and oxygen saturation of 96% on nasal cannula therapy at 3 liters per minute.
Physical examination revealed jaundiced skin and sclera, indicative of liver dysfunction, along with mild lower limb edema. Initial blood tests confirmed liver dysfunction, as demonstrated by heightened markers like alanine aminotransferase, aspartate aminotransferase, total and direct bilirubin.
Diagnostic methods ruled out HIV and autoimmune hepatitis, while identifying positive HEV IgM and IgG antibodies, corroborated by the presence of HEV RNA detected via real-time PCR, confirming an acute hepatitis E diagnosis.
Laboratory Data During the Course of Disease
Treatment and Management
The patient was prescribed intravenous magnesium isoglycyrrhizinate for liver protection and ademetionine for liver support. Empirical antimicrobial therapy was initiated with meropenem, while metagenomic next-generation sequencing (mNGS) was conducted to detect any potential pathogens without yielding relevant findings.
The patient was transferred to the Department of Liver and Infectious Diseases for specialized care. Given her diagnosis of TTP, further treatments targeting this condition were administered.
Implications and Future Research
This case underscores the need for continued research to understand the complex interactions between HEV and other disorders, such as TTP. Understanding these relationships could lead to better diagnostic protocols and more effective treatment strategies.
Physicians treating patients with hepatitis E should remain vigilant for potential extraliver manifestations, including TTP, especially in patients with severe or prolonged symptoms. Early recognition and appropriate intervention can improve patient outcomes.
The case presented here offers valuable insights into the rare relationship between HEV and TTP, highlighting the importance of ongoing research in viral hepatitis and its complications.
Conclusion
HEV remains a global health challenge, not only due to its prevalence but also because of its potential for causing a variety of complications beyond liver disease. The simultaneous occurrence of acute hepatitis E and TTP in this elderly patient provides crucial evidence supporting the virus’s role in eliciting TTP.
As medical science advances, so does our understanding of these complex diseases. Continued research will undoubtedly bring forth more insight, leading to improved patient care and a better understanding of viral hepatitis.
Stay informed about the latest developments in medical research by following our publications. Comment below with your thoughts or questions, and don’t forget to share this article on your social media platforms to spread awareness.
Join our community to receive the latest health news right in your inbox.
